CP.PHAR.249 Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity)
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis
ANALYTICAL REPORT1
CRITERIA FOR DRUG COVERAGE Tenofovir alafenamide (Vemlidy)
4-Acetoxy-N-methyl-N-ethyltryptamine Fumarate (4-AcO-MET Fumarate; 4-Acetoxy-MET Fumarate), 10 mg
Prior Authorization - Multiple Sclerosis – Vumerity® (diroximel fumarate delayed-release capsules)
Tyr-Gly-Gly-Phe-Met-OH (Met-Enkephalin) | Opioid Receptor Activator | MedChemExpress
Fumarate Hydratase-Deficient Renal Cell Carcinoma
Fumarate suppresses B-cell activation and function through direct inactivation of LYN | Nature Chemical Biology
Clinical Policy: Monomethyl Fumarate (Bafiertam)
ANALYTICAL REPORT1
Cancers | Free Full-Text | Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer
Metabolomics reveals tepotinib‐related mitochondrial dysfunction in MET‐activating mutations‐driven models - Poliaková - 2019 - The FEBS Journal - Wiley Online Library
RCSB PDB Group Summary: 910_30
Amazon.com: MET-RX, MET-RX Protein Plus Chocolate 2LB : Health & Household
4-hydroxy MET (4-HO MET, Metocin, CAS Number: 77872-41-4) | Cayman Chemical
Clinical Policy: Dimethyl fumarate (Tecfidera)
MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis: Molecular Therapy - Nucleic Acids
Antioxidants | Free Full-Text | Selenomethionine (Se-Met) Induces the Cystine/Glutamate Exchanger SLC7A11 in Cultured Human Retinal Pigment Epithelial (RPE) Cells: Implications for Antioxidant Therapy in Aging Retina
Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities | Journal of Medicinal Chemistry
Breztri Aerosphere Phase III trial meets primary endpoints
Frontiers | Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia | Oncogene
![1445751-40-5 | 4-Acetoxy-N-ethyl-N-methyltryptamine | 3-[2-(Ethylmethylamino)ethyl]-1H-Indol-4-ol 4-Acetate; 4-AcO-MET ; | C15H20N2O2 | TRC](https://www.trc-canada.com/prod-img/A190280.png "1445751-40-5 | 4-Acetoxy-N-ethyl-N-methyltryptamine | 3-[2-(Ethylmethylamino)ethyl]-1H-Indol-4-ol 4-Acetate; 4-AcO-MET ; | C15H20N2O2 | TRC")
1445751-40-5 | 4-Acetoxy-N-ethyl-N-methyltryptamine | 3-[2-(Ethylmethylamino)ethyl]-1H-Indol-4-ol 4-Acetate; 4-AcO-MET ; | C15H20N2O2 | TRC
Frontiers | Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis
